KOS PHARMACEUTICALS REVERSES TO QUARTERLY LOSS

Kos Pharmaceuticals, pharmaceutical company, reversed to a loss of 6 cents a share in Q1, hurt by inventory management agreements and stock option expenses despite 11% revenue growth. If not for those agreements and expenses, it would have earned 28 cents a share, still short of the 62 cents a share earned in the year-earlier period.

123Jump.com (http://www.123jump.com/Earning-News-Headlines/Kos-Pharmaceuticals-Reverses-to-Quarterly-Loss/3147)